CDKN2B-AS1 and gastric cancer: As shown in Figure 7A and 7B, enforced E2F1 expression could increase the expression of ANRIL and E2F1 could bind to the promoter of ANRIL. Moreover, E2F1 was upregulated in gastric cancer tissues (Figure 7C).